• 35+ New Products Eligible for Inaugural SCOPE Best of Show Awards

    Clinical Research News | Clinical Research News and ClinEco are pleased to announce the finalists for the first SCOPE Best of Show Awards. Thirty-five new products presented at the Summit for Clinical Ops Executives in February in Orlando, Fla. have been chosen as finalists in the inagural awards program, recognizing the best new products enabling clinical trials and clincial research.

    Jan 31, 2023

  • MD Anderson Launches Gamma-Delta T-Cell Therapy Study, New Multi-Year Multi-Omics Cancer Resistance Mechanisms Research, More

    Clinical Research News | A major new initiative in cancer research to study the role and function of the non-coding genome and epigenome in multiple cancer types; the first one-stop-shop decentralized clinical trial platform bundled with site and trial execution services for the digital therapeutics market; a unique and unparalleled suite of early to late-phase CRO services across Europe, the US, and Asia Pacific; and more.

    Jan 26, 2023

  • Follow the Money: PCORI Opens Nine Research Funding Opportunities, Novel Transcriptome-Wide Profiling Research, More

    Clinical Research News | Funding for preclinical development and clinical proof-of-concept therapeutic studies, comparative clinical effectiveness research to help patients and other stakeholders make better-informed health choices, clinical decision support expansion for diagnostic and surveillance tools, and more.

    Jan 24, 2023

  • Revolutionizing Payment Products is Vital for Increasing Clinical Trial Participant Satisfaction and Diversity

    Clinical Research News | Patient-centricity has become a buzzword in clinical trials, but many practical barriers still limit diversity and reduce participant satisfaction. As an industry, our true north should be making it easier to participate in clinical trials for a meaningful impact on patients and significant added value for sponsors.

    Jan 20, 2023

  • Retinal Organoid-Derived Neurons to Potentially Cure Degenerative Eye Disease

    Clinical Research News | A new study published in the Proceedings of the National Academy of Science demonstrates the potential for lab-grown retinal neurons to reestablish synaptic function and cure neurodegenerative eye disease, according to researchers from the University of Wisconsin–Madison.

    Jan 18, 2023

  • Improving Pediatric Clinical Trial Development in 2023

    Clinical Research News | A clinical trial’s path from initial design to completion is exceptionally complex. Poor patient recruitment and low retention rates complicate the clinical trial process, especially in studies for children with rare diseases. Thankfully, patient concierge services will offer immense insight into the unique support needs of individual pediatric patients and their families and increase the success rates for life-saving treatments.

    Jan 13, 2023

  • Virtual Site Brings Speed, Diversity, And Engagement To Digital Therapeutic Trial

    Clinical Research News | Digital therapeutics are a natural fit with the decentralized clinical trial model and the COVID-19 pandemic has been a major driver of demand for both. The hybrid-designed PROSPER-FM trial is a good case in point. The devices being studied are a digital Acceptance and Commitment Therapy program and digital symptom tracker for adults with fibromyalgia and the single virtual site, run by Curavit, has been enrolling 10 times more patients than all other bricks-and-mortar sites starting at the same time.

    Jan 11, 2023

  • SCOPE Preview: Patient-Centricity, Real-World Evidence, and the Evolution of Clinical Trial Design

    Clinical Research News | Clinical Research News will be attending the Summit for Clinical Ops Executives—SCOPE—in Orlando, Fla. from February 6-9, 2023. Here are just a few of the items from the agenda we’ve flagged so far.

    Jan 10, 2023

  • Trendspotting: Hybrid and Decentralized Clinical Trials, Patient-Centricity, and Increased Remote Patient Monitoring in 2023

    Clinical Research News | We spoke with clinical research leaders about their expectations for the coming year. They predicted that hybrid and decentralized trials (DCTs) would eventually become the industry standard, brick-and-mortar sites will employ flexibility to increase patient retention, and companies will rely heavily on remote patient monitoring and wearable devices to stretch their budgets and combat the looming economic downturn.

    Jan 5, 2023

  • AbbVie’s Christopher Boone on Disrupting the Clinical Research Enterprise With Real-World Data and Evidence

    Clinical Research News | In recent years, pharmaceutical and life science companies have leveraged real-world evidence (RWE) to maximize patient recruitment and formulate clinical trial criteria. In the latest episode of the Scope of Things podcast, Christopher Boone, Ph.D., vice president and global head of health economics and outcomes research at AbbVie, talks about the disruptive nature of RWE and its impact on clinical trial design.

    Jan 3, 2023

  • Top Stories of 2022: Decentralized Trials, Data Science for Trials

    Clinical Research News | Decentralized trials have been on everyone’s lips this past year. The first real data coming in on the success and value of new trial formats has also prompted other questions around standardizing vocabulary, prioritizing the incorporation of new pharmacists, and more. In addition, new data science technologies including machine learning and “tokenization” aim to shape clinical research.

    Dec 29, 2022

  • IllumiCare App Recommends Trials as Therapeutic Option, New Data Capture Interface Increases Real-World Patient Compliance, More

    Clinical Research News | A 16-gene molecular signature investigation based on gene expression differences between patients with and without local recurrence after breast-conserving surgery; analytically sensitive infectious disease panels to support laboratory research; eClinical solutions to make clinical research processes more efficient and compliant; and more.

    Dec 27, 2022

  • Follow the Money: MD Anderson’s High-Affinity Monoclonal Antibody Research, New Neurodegeneration Research Center, More

    Clinical Research News | Funding for microbial resistance and infectious disease research, tracking Long COVID in diverse pediatric and adult populations, an AI-powered platform that identifies novel cancer therapies and predicts the efficacy of cancer drug combinations, and more.

    Dec 22, 2022

  • ClinEco Helps Trial Stakeholders ‘Cut Through The Noise’ To Find One Another

    Clinical Research News | The world’s first B2B market network for clinical trials is now fully functioning and onboarding, as well as learning, from early adopters. ClinEco recently moved into the open beta stage of its development with a gratifyingly diverse mix of stakeholders registering for free membership.

    Dec 20, 2022

  • Insilico Medicine’s AI-Driven Platform Pushes The Envelope Of Drug Discovery

    Clinical Research News | During a recent virtual unveiling party livestreamed from around the world, Insilico Medicine introduced the latest updates to Pharma.AI, its end-to-end drug discovery platform using generative artificial intelligence to discover new targets, design new molecules, and predict the outcome of clinical trials. Among the highlights were the addition of a knowledge graph to target discovery product PandaOmics and numerous new panels to generative chemistry engine Chemistry42.

    Dec 15, 2022

  • In Virtual Trials, Two Alzheimer’s Drugs Do Poor Job Of Slowing Cognitive Decline

    Clinical Research News | Researchers from Duke, Penn State, and the University of Tennessee collaboratively built a mathematical model of Alzheimer’s disease that used real, de-identified patient data to simulate health outcomes from a pair of anti-amyloid-beta drugs. Notably, the virtual (aka in silico) clinical trials employed a computational approach that provides “individualized prescriptions” based on optimal timing and dosing of treatment while minimizing possible side effects.

    Dec 14, 2022

  • Killing Cancer With Synthetic Lethality

    Clinical Research News | A key member of the team that discovered the BRCA2 breast cancer susceptibility gene in 1995 is now enamored of the idea of taking on cancer with synthetic lethal therapies, a nontraditional approach that exploits the weaknesses of cancer cells. The promise of the treatment concept was the topic of the Heath Memorial Award keynote address delivered at the recent Leading Edge of Cancer Research Symposium of the University of Texas MD Anderson Cancer Center.

    Dec 13, 2022

  • 2023 Participant Engagement Awards Finalists Named

    Clinical Research News | Finalists have been named for the 7th Annual Participant Engagement Award. Winners will be announced after a live presentation and judging session at the Summit for Clinical Ops Executives. This year’s SCOPE Summit will be held February 6-9, 2023, in Orlando, Fla.

    Dec 8, 2022

  • Dr. Loaiza-Bonilla on Massive Bio’s Efforts to Make Clinical Trials More Accessible for Cancer Patients

    Clinical Research News | In the latest episode of the Scope of Things podcast, host Deborah Borfitz speaks with Dr. Arturo Loaiza-Bonilla, co-founder and chief medical officer of Massive Bio, about increasing clinical trial access for cancer patients and offering next-generation enrollment services.

    Dec 6, 2022

  • Clinical Research News, ClinEco Launch SCOPE Best of Show Awards

    Clinical Research News | The Summit for Clinical Ops Executives has long been the most impactful destination for in-depth discussions in clinical research. Now the SCOPE community will wield its significant expertise to highlight the new products powering clinical research in the SCOPE Best of Show Awards brought to you by Clinical Research News and ClinEco, the global clinical trials ecosystem and marketplace.

    Dec 1, 2022